Vivos Therapeutics Inc (VVOS) — Financial Flexibility Index
Vivos Therapeutics Inc (VVOS) has a Financial Flexibility Index of -0.11x as of March 2026. Free cash flow of $-2.92 Million (operating CF $-3.81 Million minus capex $893.00K) represents 0% of total liabilities ($26.70 Million). Also explore VVOS year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vivos Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Vivos Therapeutics Inc across 8 annual periods. Check Vivos Therapeutics Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Vivos Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Vivos Therapeutics Inc. For the full company profile including market capitalisation, see VVOS company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.48x | $-12.92 Million | $-15.26 Million | $26.70 Million | ▲ +70.7% |
| 2024 | -1.65x | $-12.12 Million | $-12.69 Million | $7.33 Million | ▼ -53.2% |
| 2023 | -1.08x | $-11.14 Million | $-11.95 Million | $10.32 Million | ▲ +48.4% |
| 2022 | -2.09x | $-18.66 Million | $-19.59 Million | $8.92 Million | ▼ -27.8% |
| 2021 | -1.64x | $-13.34 Million | $-15.73 Million | $8.15 Million | ▼ -147.6% |
| 2020 | -0.66x | $-5.56 Million | $-5.68 Million | $8.41 Million | ▼ -34.3% |
| 2019 | -0.49x | $-5.16 Million | $-5.34 Million | $10.49 Million | ▲ +59.1% |
| 2018 | -1.20x | $-4.06 Million | $-5.31 Million | $3.38 Million | — |